• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[溶血性贫血作为原发性胆汁性肝硬化患者胆红素显著升高的原因]

[Hemolytic anemia as cause of a marked bilirubin increase in primary biliary cirrhosis].

作者信息

Mahl M A, von Schönfeld J, Uppenkamp M, Breuer N

机构信息

Abtei lungen für Gastroenterologie, Universitätsklinik Essen.

出版信息

Dtsch Med Wochenschr. 1996 Oct 4;121(40):1226-8. doi: 10.1055/s-2008-1043131.

DOI:10.1055/s-2008-1043131
PMID:8925755
Abstract

HISTORY AND CLINICAL FINDINGS

16 years ago a now 53-year-old woman was found to have primary biliary cirrhosis. 5 years later, after bleeding from oesophageal varices, she had a portacaval shunt. For several years she had been taking ursodeoxycholic acid (750 mg daily). Because of steadily increasing jaundice over the past few years she presented for possible liver transplantation.

INVESTIGATIONS

There was a discrepancy between the markedly raised serum bilirubin concentration (7.8 mg/dl) and the only slightly raised or normal activities of alkaline phosphatase (247 U/l) and gamma-GT (21 U/l). Further tests confirmed that the patients had not only PBC but also Coombs-negative haemolytic anaemia (haemoglobin 10.7 g/dl, reticulocyte count 122/1000, indirect bilirubin 6.4 mg/dl, haptoglobin not demonstrated, lactate dehydrogenase 316 U/l). She had splenomegaly despite the portacaval shunt. Blood smear revealed spherocytes, but hereditary spherocytosis was not confirmed.

TREATMENT AND COURSE

A six-week interruption of taking ursodeoxycholic acid led, as expected, to a rise in the activities of serum alkaline phosphatase and gamma-GT, while haemolysis parameters were not affected.

CONCLUSION

Serum bilirubin concentration is a decisive prognostic factor in the course of primary biliary cirrhosis and is therefore of particular relevance for the indication of liver transplantation. The reported case demonstrates the importance of considering other causes of hyperbilirubinaemia.

摘要

病史与临床检查结果

16年前,一名现年53岁的女性被诊断为原发性胆汁性肝硬化。5年后,因食管静脉曲张出血,她接受了门腔分流术。数年来,她一直在服用熊去氧胆酸(每日750毫克)。由于过去几年黄疸持续加重,她前来咨询是否适合进行肝移植。

检查

血清胆红素浓度显著升高(7.8毫克/分升),而碱性磷酸酶(247 U/升)和γ-谷氨酰转移酶(21 U/升)仅轻度升高或正常,两者之间存在差异。进一步检查证实,该患者不仅患有原发性胆汁性肝硬化,还患有抗人球蛋白试验阴性的溶血性贫血(血红蛋白10.7克/分升,网织红细胞计数122/1000,间接胆红素6.4毫克/分升,未检测到触珠蛋白,乳酸脱氢酶316 U/升)。尽管做了门腔分流术,她仍有脾肿大。血涂片显示有球形红细胞,但遗传性球形红细胞增多症未得到证实。

治疗与病程

如预期的那样,停用熊去氧胆酸六周导致血清碱性磷酸酶和γ-谷氨酰转移酶活性升高,而溶血参数未受影响。

结论

血清胆红素浓度是原发性胆汁性肝硬化病程中的一个决定性预后因素,因此对于肝移植指征具有特别重要的意义。本报告病例表明,考虑高胆红素血症的其他原因很重要。

相似文献

1
[Hemolytic anemia as cause of a marked bilirubin increase in primary biliary cirrhosis].[溶血性贫血作为原发性胆汁性肝硬化患者胆红素显著升高的原因]
Dtsch Med Wochenschr. 1996 Oct 4;121(40):1226-8. doi: 10.1055/s-2008-1043131.
2
Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.原发性胆汁性肝硬化患者长期服用熊去氧胆酸后胆汁酶水平及瘙痒症状的改善
Am J Gastroenterol. 1990 Jan;85(1):15-23.
3
Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.从原发性胆汁性肝硬化向原发性胆汁性肝硬化/自身免疫性肝炎重叠综合征的演变。
Semin Liver Dis. 2008 Feb;28(1):128-34. doi: 10.1055/s-2008-1042650.
4
Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.熊去氧胆酸长期治疗原发性胆汁性肝硬化:长达12年的随访
Aliment Pharmacol Ther. 2005 Feb 1;21(3):217-26. doi: 10.1111/j.1365-2036.2005.02318.x.
5
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.熊去氧胆酸治疗原发性胆汁性肝硬化的加拿大多中心双盲随机对照试验
Hepatology. 1994 May;19(5):1149-56.
6
Evaluation of hyperbilirubinemia in acute inflammation of appendix: a prospective study of 45 cases.阑尾急性炎症中高胆红素血症的评估:45例前瞻性研究。
Kathmandu Univ Med J (KUMJ). 2006 Jul-Sep;4(3):281-9.
7
A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.一项比较秋水仙碱与熊去氧胆酸联合用药和熊去氧胆酸治疗原发性胆汁性肝硬化的随机试验。熊去氧胆酸治疗原发性胆汁性肝硬化研究组。
Hepatology. 1996 Nov;24(5):1098-103. doi: 10.1002/hep.510240520.
8
PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody.伴有特发性血小板减少性紫癜和抗着丝点抗体阳性的桥本氏病的原发性胆汁性胆管炎-自身免疫性肝炎重叠综合征。
J Gastroenterol. 2004;39(5):490-5. doi: 10.1007/s00535-003-1322-5.
9
Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.原发性胆汁性肝硬化及原发性胆汁性肝硬化-自身免疫性肝炎重叠综合征的临床、生化特征及治疗反应
Hepatogastroenterology. 2002 Sep-Oct;49(47):1195-200.
10
Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.熊去氧胆酸治疗的原发性胆汁性肝硬化患者肝纤维化和淋巴细胞性碎屑样坏死的生化标志物
Liver Int. 2004 Jun;24(3):187-93. doi: 10.1111/j.1478-3231.2004.0918.x.

引用本文的文献

1
Living donor liver transplantion for primary biliary cirrhosis with autoimmune hemolytic anemia: a case report.
Dig Dis Sci. 2007 Nov;52(11):3237-9. doi: 10.1007/s10620-006-9396-6. Epub 2007 Apr 6.
2
Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant.非肝硬化性原发性胆汁性肝硬化中的黄疸:早发性胆管缺失变异型
Gut. 2001 Aug;49(2):276-81. doi: 10.1136/gut.49.2.276.